Cambridge Investment Research Advisors’s QuidelOrtho QDEL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,456	Closed	-$239K	–	3145
2022 Q2	$239K	Sell	2,456 -685	-22%	-$69.8K	﹤0.01%	2573
2022 Q1	$353K	Buy	3,141 +1,154	+58%	+$123K	﹤0.01%	2410
2021 Q4	$268K	Buy	1,987 +283	+17%	+$39.4K	﹤0.01%	2639
2021 Q3	$241K	Sell	1,704 -7,010	-80%	-$942K	﹤0.01%	2645
2021 Q2	$1.12M	Sell	8,714 -34	-0.4%	-$4K	0.01%	1460
2021 Q1	$1.12M	Sell	8,748 -3,985	-31%	-$736K	0.01%	1358
2020 Q4	$2.29M	Sell	12,733 -421	-3%	-$93.6K	0.01%	862
2020 Q3	$2.89M	Buy	13,154 +7,550	+135%	+$1.68M	0.02%	638
2020 Q2	$1.25M	Sell	5,604 -655	-10%	-$103K	0.01%	994
2020 Q1	$612K	Buy	+6,259	New	+$506K	0.01%	1253

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Cambridge Investment Research Advisors's QDEL Position: Q3 2022 in Review

Cambridge Investment Research Advisors sold out of QuidelOrtho (QDEL) in Q3 2022, closing a stake of 2,456 shares — an estimated $239K sold.

Cambridge Investment Research Advisors first reported a position in QDEL in Q1 2020 and held it in 10 quarters. The position peaked at $2.89M in Q3 2020. 315 funds tracked by Wall St. Rank hold QDEL as of Q3 2022.

Cambridge Investment Research Advisors reported no remaining QuidelOrtho position as of Q3 2022 after selling out during the quarter.
Cambridge Investment Research Advisors sold 2,456 QuidelOrtho shares in Q3 2022, an estimated $239K.
Cambridge Investment Research Advisors first reported a position in QuidelOrtho in Q1 2020 and held it in 10 quarters.
Cambridge Investment Research Advisors's QuidelOrtho position peaked at $2.89M in Q3 2020.
315 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.